Компания XM не предоставляет услуги резидентам Соединенных штатов Америки.
A
A

Agilent


Новости

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Mattel, Tellurian Updates: Clearwater Paper, Agilent July 22 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1955 GMT on Monday: * * L Catterton, the private equity firm backed by luxury goods giant LVMH LVMH.PA , has approached Mattel MAT.O , the toy maker behind Barbie and Hot Wheels, with an acquisition offer, people familiar with the matter said.
A
G
H
L
M
V
D

Agilent Technologies To Acquire BIOVECTRA for $925 Million

BRIEF-Agilent Technologies To Acquire BIOVECTRA for $925 Million July 22 (Reuters) - Agilent Technologies Inc A.N : AGILENT TO ACQUIRE NORTH AMERICAN CDMO BIOVECTRA AGILENT TECHNOLOGIES INC - TO ACQUIRE BIOVECTRA FOR $925 MILLION AGILENT TECHNOLOGIES INC - EXPECTS ACQUISITION TO BE $0.05 DILUTIVE TO NON-GAAP EPS Source text for Eikon: ID:nBw5TcW1Fa
A

Agilent to buy contract drug manufacturer Biovectra for $925 mln

UPDATE 2-Agilent to buy contract drug manufacturer Biovectra for $925 mln Adds deal details in paragraph 5 and background throughout July 22 (Reuters) - Agilent Technologies A.N said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
A

Agilent to buy contract drug manufacturer Biovectra for $925 million

Agilent to buy contract drug manufacturer Biovectra for $925 million July 22 (Reuters) - Medical equipment maker Agilent Technologies A.N said on Monday it will acquire privately held contract drug manufacturer Biovectra for $925 million. Reporting by Mariam Sunny in Bengaluru; Editing by Shounak Dasgupta
A

U.S. Elevance Health, J&J, Primerica

U.S. RESEARCH ROUNDUP-Elevance Health, J&J, Primerica July 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Elevance Health, J&J and Primerica, on Thursday. HIGHLIGHTS * Elevance Health Inc ELV.N : Leerink Partners cuts target price to $620 from $630 * J&J JNJ.N : TD Cowen cuts target price to $185 from $195 * Primerica Inc PRI.N : Jefferies raises target price to $249 from $239 * Travelers Companies Inc TRV.N : HS
A
A
O
P
Q
A
A
C

U.S. Nvidia, Qualcomm, Tesla

U.S. RESEARCH ROUNDUP-Nvidia, Qualcomm, Tesla July 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Nvidia, Qualcomm and Tesla, on Wednesday. HIGHLIGHTS * Brighthouse Financial Inc BHF.O : Jefferies raises to buy from hold * Legalzoom.Com Inc LZ.O : JP Morgan cuts to neutral from overweight * Nvidia Corp NVDA.O : KeyBanc raises target price to $180 * Qualcomm Inc QCOM.O : KeyBanc raises target price to $225 * Tesla
A
A
A
A
A
C
G
M
M
N
P
Q
S
T
A
A
A
C
O
B
T
A
A
A
A
C
G
L
U

Masimo COO Muhsin to resign if activist investor Politan takes control

UPDATE 2-Masimo COO Muhsin to resign if activist investor Politan takes control Adds background throughout July 1 (Reuters) - Masimo MASI.O Chief Operating Officer Bilal Muhsin has told the board he would resign if activist investor Politan Capital Management takes control of the company and CEO Joe Kiani is removed, according to a regulatory filing.
A
S

U.S. Alimera Sciences, Comtech Telecommunications, Eli Lilly

U.S. RESEARCH ROUNDUP-Alimera Sciences, Comtech Telecommunications, Eli Lilly June 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alimera Sciences, Comtech Telecommunications and Eli Lilly, on Tuesday. HIGHLIGHTS * Alimera Sciences Inc ALIM.O : Craig-Hallum cuts to hold from buy * Comtech Telecommunications Corp CMTL.O : Jefferies raises to hold from underperform * Eli Lilly LLY.N : Truist Securities raises targe
A
A
E
D
U
V
A
B
C
C
C
F
M

EU to impose duties of up to 38% on Chinese electric vehicles

CORRECTED-INSTANT VIEW-EU to impose duties of up to 38% on Chinese electric vehicles Corrects attribution of comment in paragraph 49 to EUROPEAN UNION CHAMBER OF COMMERCE IN CHINA June 12 (Reuters) - The European Commission said on Wednesday it would set provisional duties of up to 38.1% on imports of Chinese electric vehicles, a move likely to draw possible retaliation from China.
A
B
P
R
T
V

EU to impose duties of up to 38% on Chinese electric vehicles

INSTANT VIEW-EU to impose duties of up to 38% on Chinese electric vehicles Adds new comments June 12 (Reuters) - The European Commission said on Wednesday it would set provisional duties of up to 38.1% on imports of Chinese electric vehicles, a move likely to draw possible retaliation from China. COMMENTARY: Carmakers OLIVER ZIPSE, CEO, BMW BMWG.DE "This decision for additional import duties is the wrong way to go.
A
B
P
T
V

EU to impose duties of up to 38% on Chinese electric vehicles

INSTANT VIEW-EU to impose duties of up to 38% on Chinese electric vehicles Adds new comments June 12 (Reuters) - The European Commission said on Wednesday it would set provisional duties of up to 38.1% on imports of Chinese electric vehicles, a move likely to draw possible retaliation from China. COMMENTARY: Carmakers VOLKSWAGEN VOWG_p.DE : "Countervailing duties are generally not suitable for strengthening the competitiveness of the European automotive industry in the long term - we reject them
A
B
P
V

U.S. Asana, GE Vernova, New Gold

U.S. RESEARCH ROUNDUP-Asana, GE Vernova, New Gold June 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Asana, GE Vernova and New Gold, on Monday. HIGHLIGHTS * Asana ASAN.N : HSBC raises to hold from reduce * GE Vernova Inc GEV.N : JP Morgan raises target price to $186 from $176 * New Gold Inc NGD.N : CIBC raises to outperformer from neutral * Owens Corning OC.N : Barclays raises target price to $190 from $160 * Rad
A
A
B
B
I
S
A
A
E
M
M
P

U.S. Connectone Bancorp, Hormel Foods, UMB Financial

U.S. RESEARCH ROUNDUP-Connectone Bancorp, Hormel Foods, UMB Financial May 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Connectone Bancorp, Hormel Foods and UMB Financial, on Friday. HIGHLIGHTS * Connectone Bancorp Inc CNOB.O : KBW cuts to market perform from outperform * Hancock Whitney Corp HWC.O : KBW raises to outperform from market perform * Hormel Foods Corp HRL.N : JP Morgan raises to neutral from underwe
A
A
C
M
M
N
P
S
A
U
A
B
D
E
E
X
M

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change HP Inc HPQ.N +17.1% Best Buy Co Inc BBY.N +13.3% Warner Bros Discovery Inc WBD.OQ +6.1% Bath & Body Works Inc BBWI.N +4.2% CVS Health Corp CVS.N +4.2% Bottom Performers Percent Change Salesforce Inc CRM.N -20.8% ServiceNow Inc NOW.N -1
A
S
U
S

U.S. STOCKS HP, Salesforce, C3.ai

BUZZ-U.S. STOCKS ON THE MOVE-HP, Salesforce, C3.ai Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes fell on Thursday, with a plummeting Salesforce weighing on the Dow, while data showing the economy had grown slower than previously expected in the first quarter supported bets of rate cuts from the Federal Reserve this year.
A
J
P
S
T
A
U
U
D
G
S
W

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change HP Inc HPQ.N +17.1% Best Buy Co Inc BBY.N +11.4% ETSY Inc ETSY.OQ +4.1% Insulet Corp PODD.OQ +4.0% Enphase Energy Inc ENPH.OQ +3.8% Bottom Performers Percent Change Salesforce Inc CRM.N -20.4% ServiceNow Inc NOW.N -9.5% Hormel Foods Co
A
S
U
E
S
W

Agilent hits 6-month low after cutting full-year revenue forecast

BUZZ-Agilent hits 6-month low after cutting full-year revenue forecast Updates ** Shares of medical equipment maker Agilent Technologies A.N fall as much as 1 3.9 % to a six-month low of $125.30 * * Stock set for its biggest one-day pct. drop in five years if losses hold ** Co late Wednesday lowered full-year revenue forecast to between $6.42 bln a
A

Waters Corp dips over peer Agilent's FY revenue forecast cut

BUZZ-Waters Corp dips over peer Agilent's FY revenue forecast cut ** Shares of lab equipment maker Waters Corp WAT.N fall 5% to $310.84 in early morning trade after peer Agilent Technologies A.N lowers annual revenue forecast ** Agilent's FY forecast cut and narrow Q2 revenue est. miss on Wednesday was due to soft demand from its biotech customers
A
W

U.S. STOCKS Agilent, Best Buy, C3.ai

BUZZ-U.S. STOCKS ON THE MOVE-Agilent, Best Buy, C3.ai Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures pared early losses on Thursday after data showed the U.S. economy grew more slowly in the first quarter than previously estimated, boosting hopes for interest rate cuts from the Federal Reserve this year.
A
P
S
T
A
U

Agilent slides after cutting full-year revenue forecast

BUZZ-Agilent slides after cutting full-year revenue forecast ** Shares of medical equipment maker Agilent Technologies A.N fall 13.1% to $126.50 premarket ** Co late Wednesday lowered full-year revenue forecast to between $6.42 bln and $6.50 bln, down from $6.71 bln to $6.81 bln ** Agilent's Q2 revenue of $1.57 bln missed Wall Street estimates of $
A



Условия

Попул. активы

Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.

Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.

Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.

Предупреждение о риске. Вы рискуете потерять свой капитал. Торговля маржинальными продуктами подходит не всем инвесторам. Пожалуйста, ознакомьтесь с нашим Предупреждением о рисках.